Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001829126-23-008158)

Filing Details

Accession Number:: 0001829126-23-008158
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2023-12-21 16:01:40
Reporting Period:: 2023-06-28

Accepted Time:: 2023-12-21 16:01:40
Original Submission Date:: 2023-06-30
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1557376	Organicell Regenerative Medicine Inc.	OCEL	Biological Products, (No Disgnostic Substances) (2836)	474180540

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1888273	L. Harry Leider	3321 College Avenue Suite 246 Davie FL 33314	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-28	549,450	$0.01	549,450	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2023-06-29	500,000	$0.01	1,049,450	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote
No	4	P	Indirect	See footnote

Footnotes

The shares are held by the Harry L. Leider Revocable Trust of which the Reporting Person is the Trustee. The purpose of this Amendment is to correct the purchase price for the shares purchased on June 28, 2023.